Neurosciences articles for Italy

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 109

Article ‘Count’ for Neurosciences.

Journal Count Share
1 0.70
Enhancing Thrombolysis Safety in Post-Acute Ischemic Stroke with Tissue Plasminogen Activator-Associated Microparticles 0.70
1 0.17
Repeated loading and damage progression in cerebral arteries 0.17
1 0.45
Monitoring the Switching from Base-on to Base-off Forms of Vitamin B12 by Natural and Magnetic Circular Dichroism Spectroscopies 0.45
1 0.09
The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects. 0.09
2 1.50
Modeling Midbrain and Brainstem Neuromelanins to Characterize Metal Binding and Associated MRI Contrast in Parkinson's and Alzheimer's Diseases 0.50
Multiple and Alternative Sites Make Tau Protein an Adaptable Sticky Surface for the SH3 Domain of Fyn Kinase 1.00
14 4.64
Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis 0.08
Human Brain Contusions Contain Pathogenic Transmissible Species that Induce Progressive Cognitive Decline and Tau Pathology in Mice 0.88
Population‐Based Epidemiology of Autoimmune Seizures and Epilepsies 0.02
CSF-Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery 0.06
Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling 0.05
<atl>Effects of Intradural Extension of Extracranial Cervical Artery Dissection on Outcomes: A Secondary Analysis From the scpSTOP/scp ‐ scpCAD/scp Study</atl> 0.03
The Epidemiology of Primary Lateral Sclerosis: Results from a Population‐Based Cohort 1.00
Mutations in the Key Autophagy Tethering Factor scpEPG5/scp Link Neurodevelopmental and Neurodegenerative Disorders Including Early‐Onset Parkinsonism 0.01
From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis 0.09
The Role of Electroencephalography in Predicting Post-Stroke Seizures and an Updated Prognostic Model (SeLECT-EEG) 0.17
Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis 0.99
High‐Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis 0.06
Deep Brain Stimulation for scpiVPS16/i/scp‐Related Dystonia: A Multicenter Study 0.21
α‐Synuclein‐Related Mitochondria‐Nrf2 Dysfunction in Parkinson's Disease Olfactory Mucosa 1.00
11 2.56
Evidence of skull bone translocator protein overexpression linked to multiple sclerosis progression 0.19
Multimodal multicentre investigation of diagnostic and prognostic markers in disorders of consciousness 0.22
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study 0.02
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers 0.14
Skin intraneural phosphorylated α-synuclein is a highly specific biomarker for early Parkinson’s disease 0.87
Genotype-specific interferon signatures in amyotrophic lateral sclerosis relate to disease severity 0.46
Advanced oxidation protein products activated TRPA1 in a neuropathic multiple sclerosis model 0.23
Associations between epilepsy-related polygenic risk and brain morphology in childhood 0.13
Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients 0.05
Charcot-Marie-Tooth disease type 1E: clinical natural history and molecular impact of iPMP22/i variants 0.15
Anatomical progression of genetic frontotemporal lobar degeneration across the lifespan 0.10
1 0.06
Astrocytes functionally integrate multiple synapses via specialized leaflet domains 0.06
1 0.10
Endoplasmic reticulum Nogo drives AgRP neuronal activation and feeding behavior 0.10
1 1.00
Changing Clinical and Laboratory Characteristics of Progressive Multifocal Leukoencephalopathy: A Retrospective National Cohort Study 1.00
1 0.30
Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosis 0.30
1 0.10
Multivariate Brain-Blood Signatures in Early-Stage Depression and Psychosis 0.10
5 1.34
Anti-nephrin antibodies are not enriched in patients with primary and post-transplant recurrent podocytopathies 1.00
Pathogenic variants in BORCS5 Cause a Spectrum of Neurodevelopmental and Neurodegenerative Disorders with Lysosomal Dysfunction 0.03
N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in Parkinson’s disease models 0.15
ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis 0.06
Sensory neuron–expressed FGF13 controls nociceptive signaling in diabetic neuropathy models 0.10
3 0.58
Hierarchical afferent connectivity drives population-wide bursting dynamics in a computational model of human-derived excitatory neuronal networks 0.25
Toward Unified Biomarkers for Focal Epilepsy 0.20
ALS mutations shift the isoelectric point of the KIF5A C-terminal inducing protein aggregation and TDP-43 mislocalization 0.13
5 2.81
TRIP8bnano peptide prevents cAMP binding to HCN2 channels alleviating pain-like behaviors in rats with neuropathic pain 0.50
α‐Synuclein oligomers slow down action potential firing and enhance dopamine release by increasing Cav2.2 currents in midbrain dopaminergic neurons 1.00
Ageing does not impair motor neuron adaptations: comparable motor unit responses to strength training in young and older adults 0.42
Lactate potentiates NMDA receptor currents via an intracellular redox mechanism targeting GluN2B subunits: implications for synaptic plasticity 0.18
Neural determinants of the increase in muscle strength and force steadiness of the untrained limb following a 4 week unilateral training 0.71
2 0.32
Femtosecond Soft X-ray Absorption Spectroscopy Identifies Metal-Centered S1 Excited State of Cyanocobalamin 0.02
Small Protein Domains as Potential Spin Labels for In Vitro, Cellular, and Light-Induced Dipolar EPR Spectroscopy 0.30
1 0.05
Risk models of cancer-related cognitive complaints among early breast cancer survivors in the CANTO cohort 0.05
3 1.83
The role of neural derived extracellular vesicles micro-ribonucleic acid cargo in white matter integrity in early-onset and late-onset bipolar disorder 1.00
Cortical microstructure is associated with disease severity and clinical progression in genetic frontotemporal dementia: a GENFI study 0.10
CLN5 deficiency impairs glucose uptake and uncovers PHGDH as a potential biomarker in Batten disease 0.73
2 0.13
A probabilistic histological atlas of the human brain for MRI segmentation 0.01
Synthetic α-synuclein fibrils replicate in mice causing MSA-like pathology 0.12
1 0.13
Endoplasmic reticulum–mitochondria contacts are prime hotspots of phospholipid peroxidation driving ferroptosis 0.13
13 3.56
Oxidative stress causes a reversible decrease of deubiquitylases activity in old vertebrate brains 0.27
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality 0.11
Targeted antisense oligonucleotide treatment rescues developmental alterations in spinal muscular atrophy organoids 0.96
Development of [F]ACI-19626 as a first-in-class brain PET tracer for imaging TDP-43 pathology 0.08
Status dystonicus is a distinct state characterized by pallidal beta-band activity 0.04
Astrocytes modulate neuronal development by S100A6 signaling 0.13
Estrogen-related receptor gene expression associates with sex differences in cortical atrophy in isolated REM sleep behavior disorder 0.13
Synthetic chaperone based on Hsp90-Tau interaction inhibits Tau aggregation and rescues physiological Tau-Microtubule interaction 0.08
Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids 0.63
Targeting prostaglandin E2 receptor 2 in Schwann cells inhibits inflammatory pain but not inflammation 0.72
Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification 0.23
Choroid plexus-mediated CSF secretion remains stable in aging rats via high and age-resistant metabolic activity 0.13
Control of spatiotemporal activation of organ-specific fibers in the swine vagus nerve by intermittent interferential current stimulation 0.06
1 0.03
Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis 0.03
6 0.78
Microbiome signature of Parkinson’s disease in healthy and genetically at-risk individuals 0.26
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders 0.16
High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial 0.05
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial 0.06
Pridopidine in early-stage manifest Huntington’s disease: a phase 3 trial 0.05
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis 0.21
4 0.24
White matter pathways mediating dorsolateral prefrontal TMS therapy for depression 0.05
Adversarial AI reveals mechanisms and treatments for disorders of consciousness 0.01
Diversity and immune dynamics of choroid plexus macrophages are shaped by distinct developmental origins 0.11
Muscle-derived miR-126 regulates TDP-43 axonal local synthesis and NMJ integrity in ALS models 0.07
1 0.03
Neurons undergo IFNγ-driven persistent epigenetic shifts and synaptopathy in encephalitis 0.03
1 0.95
Combining gamma neuromodulation and robotic rehabilitation after a stroke restores parvalbumin interneuron dynamics and improves motor recovery in mice 0.95
5 2.26
Metabolic trajectories in developing human neocortical neurons 1.00
Preservation of anticorrelated brain networks predicts recovery after traumatic brain injury 0.15
Dysregulated proteostasis in p.A53T-α-Synuclein astrocytes aggravates Lewy-like neuropathology in a Parkinson’s disease iPSC model 0.03
Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology 0.12
Spontaneous activity of astrocytes is a stochastic functional signal for memory consolidation 0.96
1 0.09
Brain MRI Analysis of Cumulative Blast Exposure and Intracranial Aneurysms in Special Operations Forces. 0.09
1 0.01
Blocking RAN translation without altering repeat RNAs rescues C9ORF72-related ALS and FTD phenotypes 0.01
4 0.97
Enteric botulinum neurotoxins facilitate infection by Salmonella and Shigella 0.83
Preventing neuropathy and improving anticancer chemotherapy with a carbazole-based compound 0.03
The chloride intracellular channel 1 (CLIC1) is essential for microglial morphodynamics and neuroinflammation 0.07
Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primates 0.04
3 1.32
Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer’s disease models 0.03
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis 0.35
Reconnecting the vagus nerve to the heart through nerve conduit preserves cardiac function in a minipig model of right cardiac vagotomy 0.94
1 0.04
Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2 0.04
2 1.60
Multiscale Simulation of Photoinduced Electron Transfer in Cryptochrome 4 from European Robin and Pigeon Indicates a Conserved Dynamics 1.00
Thermodynamics Analysis of a Reaction-Diffusion Matrix Multiplication Computing Unit under the Linear Non-Equilibrium Regime 0.60
1 0.04
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial 0.04
3 0.24
Association between the Edinburgh CT and genetic diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage and recurrent intracerebral haemorrhage: an individual patient data meta-analysis 0.09
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial 0.12
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study 0.03
4 0.20
Asundexian for Secondary Stroke Prevention 0.02
Fremanezumab in Children and Adolescents with Episodic Migraine 0.09
Risdiplam in Presymptomatic Spinal Muscular Atrophy 0.05
Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1 0.05

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.